Hepatitis C virus infection: A "liaison a trois" amongst the virus, the host, and chronic low-level inflammation for human survival

Journal of Hepatology

Volumn 53, Issue 4, 2010, Pages 752-761

  Barnaba, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adaptive immunity; B cells; Dendritic cells; Hepatitis C virus; Immune regulation; Immune subversion; Immunopathology; Innate immunity; T cell exhaustion; T cells

Indexed keywords

CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; HEPATITIS C VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; PATTERN RECOGNITION RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN PD L1; PROTEIN PD L2; PROTEIN TYROSINE PHOSPHATASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACUTE HEPATITIS; ACUTE PHASE RESPONSE; ADAPTIVE IMMUNITY; B LYMPHOCYTE ACTIVATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CROSS PRESENTATION; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HOST; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LIVER INJURY; LIVER PROTECTION; MEMORY T LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SENSORY EVALUATION; SPECIES; SRC HOMOLOGY DOMAIN; SURVIVAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS INFECTIVITY; VIRUS MUTATION;

ADAPTIVE IMMUNITY; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION;

EID: 77956262321     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.003     Document Type: Review

References (93)

1. B. Rehermann Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence J Clin Invest 119 2009 1745 1754
2. L.B. Dustin, and C.M. Rice Flying under the radar: the immunobiology of hepatitis C Annu Rev Immunol 25 2007 71 99
3. M.L. Albert, J. Decalf, and S. Pol Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C J Hepatol 49 2008 1069 1078
4. P. Matzinger Tolerance, danger, and the extended family Annu Rev Immunol 12 1994 991 1045
5. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
6. J.H. Fritz, R.L. Ferrero, D.J. Philpott, and S.E. Girardin Nod-like proteins in immunity, inflammation and disease Nat Immunol 7 2006 1250 1257
7. E. Meylan, J. Tschopp, and M. Karin Intracellular pattern recognition receptors in the host response Nature 442 2006 39 44
8. V. Petrilli, C. Dostert, D.A. Muruve, and J. Tschopp The inflammasome: a danger sensing complex triggering innate immunity Curr Opin Immunol 19 2007 615 622
9. S.Y. Yuen, and J.E. Pope Leaning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials Arthritis Rheum 56 2007 4294
10. Y.M. Loo, D.M. Owen, K. Li, A.K. Erickson, C.L. Johnson, and P.M. Fish Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection Proc Natl Acad Sci USA 103 2006 6001 6006
11. D.L. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
12. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, and C. O'HUigin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
13. P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, and R. Petracca Binding of hepatitis C virus to CD81 Science 282 1998 938 941
14. M.J. Evans, T. von Hahn, D.M. Tscherne, A.J. Syder, M. Panis, and B. Wolk Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry Nature 446 2007 801 805
15. J. Decalf, S. Fernandes, R. Longman, M. Ahloulay, F. Audat, and F. Lefrerre Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients J Exp Med 204 2007 2423 2437
16. R.S. Longman, A.H. Talal, I.M. Jacobson, C.M. Rice, and M.L. Albert Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C J Infect Dis 192 2005 497 503
17. A. Lanzavecchia, and F. Sallusto Regulation of T cell immunity by dendritic cells Cell 106 2001 263 266
18. R.M. Steinman, D. Hawiger, and M.C. Nussenzweig Tolerogenic dendritic cells Annu Rev Immunol 21 2003 685 711
19. T. Kanto, N. Hayashi, T. Takehara, T. Tatsumi, N. Kuzushita, and A. Ito Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals J Immunol 162 1999 5584 5591
20. R.S. Longman, A.H. Talal, I.M. Jacobson, M.L. Albert, and C.M. Rice Presence of functional dendritic cells in patients chronically infected with hepatitis C virus Blood 103 2004 1026 1029
21. A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, and L. Romics Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation J Immunol 170 2003 5615 5624
22. A.L. Eisen-Vandervelde, S.N. Waggoner, Z.Q. Yao, E.M. Cale, C.S. Hahn, and Y.S. Hahn Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation J Biol Chem 279 2004 43479 43486
23. S.I. Khakoo, C.L. Thio, M.P. Martin, C.R. Brooks, X.J. Gao, and J. Astemborski HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874
24. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, and D. Mavilio Natural killer cell functional dichotomy in chronic hepatitis b and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160
25. S. Crotta, A. Stilla, A. Wack, A. D'Andrea, S. Nuti, and U. D'Oro Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein J Exp Med 195 2002 35 41
26. C.T.K. Tseng, and G.R. Klimpel Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions J Exp Med 195 2002 43 49
27. R. Ahmed, M.J. Bevan, S.L. Reiner, and D.T. Fearon The precursors of memory: models and controversies Nat Rev Immunol 9 2009 662 668
28. C.D. Surh, O. Boyman, J.F. Purton, and J. Sprent Homeostasis of memory T cells Immunol Rev 211 2006 154 163
29. P. Scognamiglio, D. Accapezzato, M.A. Casciaro, A. Cacciani, M. Artini, and G. Bruno Presence of effector CD8(+) T cells in hepatitis C virus-exposed healthy seronegative donors J Immunol 162 1999 6681 6689
30. E. Mizukoshi, C. Eisenbach, B.R. Edlin, K.P. Newton, S. Raghuraman, and C. Weiler-Normann Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV J Infect Dis 198 2008 203 212
31. A. Takaki, M. Wiese, G. Maertens, E. Depla, U. Seifert, and A. Liebetrau Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C Nat Med 6 2000 578 582
32. N. Semmo, M. Lucas, G. Krashias, G. Lauer, H. Chapel, and P. Klenerman Maintenance of HCV-specific T-cell responses in anti body-deficient patients a decade after early therapy Blood 107 2006 4570 4571
33. J.M. Pestka, M.B. Zeisel, E. Blaser, P. Schurmann, B. Bartoscht, and F.L. Cosset Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C Proc Natl Acad Sci USA 104 2007 6025 6030
34. V. Francavilla, D. Accapezzato, M. De Salvo, P. Rawson, O. Cosimi, and M. Lipp Subversion of effector CD8(+) T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms Eur J Immunol 34 2004 427 437
35. D.E. Kaplan, K. Sugimoto, K. Newton, M.E. Valiga, F. Ikeda, and A. Aytaman Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C Gastroenterology 132 2007 654 666
36. S. Urbani, B. Amadei, P. Fisicaro, D. Tola, A. Orlandini, and L. Sacchelli Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses Hepatology 44 2006 126 139
37. A.H. Sharpe, E.J. Wherry, R. Ahmed, and G.J. Freeman The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection Nat Immunol 8 2007 239 245
38. M.E. Keir, L.M. Francisco, and A.H. Sharpe PD-1 and its ligands in T-cell immunity Curr Opin Immunol 19 2007 309 314
39. L. Trautmann, L. Janbazian, N. Chomont, E.A. Said, S. Gimmig, and B. Bessette Upregulation of PD-1 expression on HIV-specific CD8(+) T cells leads to reversible immune dysfunction Nat Med 12 2006 1198 1202
40. S. Urbani, B. Amadei, D. Tola, M. Massari, S. Schivazappa, and G. Missale PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion J Virol 80 2006 11398 11403
41. N. Nakamoto, D.E. Kaplan, J. Coleclough, Y. Li, M.E. Valiga, and M. Kaminski Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization Gastroenterology 134 2008 1927 1937
42. D.G. Bowen, N.H. Shoukry, A. Grakoui, M.J. Fuller, A.G. Cawthon, and C. Dong Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection J Virol 82 2008 5109 5114
43. H.M. Diepolder, R. Zachoval, R.M. Hoffmann, E.A. Wierenga, T. Santantonio, and M.C. Jung Possible mechanism involving T-lymphocyte response to nonstructural protein-3 in viral clearance in acute hepatitis-C virus-infection Lancet 346 1995 1006 1007
44. G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari, and C. Mori Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J Clin Invest 98 1996 706 714
45. A. Grakoui, N.H. Shoukry, D.J. Woollard, J.H. Han, H.L. Hanson, and J. Ghrayeb HCV persistence and immune evasion in the absence of memory T cell help Science 302 2003 659 662
46. N.H. Shoukry, A. Grakoui, M. Houghton, D.Y. Chien, J. Ghrayeb, and K.A. Reimann Memory CD8(+) T cells are required for protection from persistent hepatitis C virus infection J Exp Med 197 2003 1645 1655
47. A.G. Rowan, J.M. Fletcher, E.J. Ryan, B. Moran, J.E. Hegarty, and C. O'Farrelly Hepatitis C virus-specific th17 cells are suppressed by virus-induced TGF-β J Immunol 181 2008 4485 4494
48. A.M. Intlekofer, A. Banerjee, N. Takemoto, S.M. Gordon, C.S. DeJong, and H.N. Shin Anomalous type 17 response to viral infection by CD8(+) T cells lacking T-bet and eomesodermin Science 321 2008 408 411
49. W.Q. Hou, H.S. Kang, and B.S. Kim Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection J Exp Med 206 2009 313 328
50. S. Burgdorf, A. Kautz, V. Bohnert, P.A. Knolle, and C. Kurts Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation Science 316 2007 612 616
51. D. Dudziak, A.O. Kamphorst, G.F. Heidkamp, V.R. Buchholz, C. Trumpfheller, and S. Yamazaki Differential antigen processing by dendritic cell subsets in vivo Science 315 2007 107 111
52. P. Guermonprez, L. Saveanu, M. Kleijmeer, J. Davoust, P. van Endert, and S. Amigorena ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells Nature 425 2003 397 402
53. D. Accapezzato, V. Visco, V. Francavilla, C. Molette, T. Donato, and M. Paroli Chloroquine enhances human CD8(+) T cell responses against soluble antigens in vivo J Exp Med 202 2005 817 828
54. M.E. Keir, S.C. Liang, I. Guleria, Y.E. Latchman, A. Qipo, and L.A. Albacker Tissue expression of PD-L1 mediates peripheral T cell tolerance J Exp Med 203 2006 883 895
55. M. Muhlbauer, M. Fleck, C. Schutz, T. Weiss, M. Froh, and C. Blank PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis J Hepatol 45 2006 520 528
56. A. Franco, V. Barnaba, P. Natali, C. Balsano, A. Musca, and F. Balsano Expression of class I and class II major histocompatibility complex antigens on human hepatocytes Hepatology 8 1988 449 454
57. A.L. Cox, T. Mosbruger, Q. Mao, Z. Liu, X.H. Wang, and H.C. Yang Cellular immune selection with hepatitis C virus persistence in humans J Exp Med 201 2005 1741 1752
58. C. Neumann-Haefelin, J. Timm, H.C. Spangenberg, N. Wischniowski, N. Nazarova, and N. Kersting Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection Hepatology 47 2008 1824 1836
59. E. Dazert, C. Neumann-Haefelin, S. Bressanelli, K. Fitzmaurice, J. Kort, and J. Timm Loss of viral fitness and cross-recognition by CD8(+) T cells limit HCV escape from a protective HLA-B27-restricted human immune response J Clin Invest 119 2009 376 386
60. L. Uebelhoer, J.H. Han, B. Callendret, G. Mateu, N.H. Shoukry, and H.L. Hanson Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness PLoS Pathog 4 2008 e1000143
61. S. Salloum, C. Oniangue-Ndza, C. Neumann-Haefelin, L. Hudson, S. Giugliano, and M.A.D. Siepen Escape from HLA-B08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs J Virol 82 2008 11803 11812
62. Z.Q. Yao, A. Eisen-Vandervelde, S.N. Waggoner, E.M. Cale, and Y.S. Hahn Direct binding of hepatitis C virus core to gC1qR on CD4(+) and CD8(+) T cells leads to impaired activation of Lck and Akt J Virol 78 2004 6409 6419
63. D. Accapezzato, V. Francavilia, P. Rawson, A. Cerino, A. Cividini, and M.U. Mondelli Subversion of effector CD8(+) T cell differentiation in acute hepatitis C virus infection: the role of the virus Eur J Immunol 34 2004 438 446
64. D.E. Kaplan, F. Ikeda, Y. Li, N. Nakamoto, S. Ganesan, and M.E. Valiga Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis J Hepatol 48 2008 903 913
65. D. Accapezzato, V. Francavilla, M. Paroli, M. Casciaro, L.V. Chircu, and A. Cividini Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection J Clin Invest 113 2004 963 972
66. M. Abel, D. Sene, S. Pol, M. Bourliere, T. Poynard, and F. Charlotte Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection Hepatology 44 2006 1607 1616
67. N. Alatrakchi, C.S. Graham, H.J.J. van der Vliet, K.E. Sherman, M.A. Exley, and M.J. Koziel Hepatitis C virus (HCV)-specific CD8(+) cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses J Virol 81 2007 5882 5892
68. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 2003 253 257
69. E.M. Shevach CD4(+)CD25(+) suppressor T cells: more questions than answers Nat Rev Immunol 2 2002 389 400
70. H. von Boehmer Mechanisms of suppression by suppressor T cells Nat Immunol 6 2005 338 344
71. S. Sakaguchi Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562
72. P.J. Coffer, and B.M.T. Burgering Forkhead-box transcription factors and their role in the immune system Nat Rev Immunol 4 2004 889 899
73. J.D. Fontenot, J.P. Rasmussen, M.A. Gavin, and A.Y. Rudensky A function for interleukin 2 in Foxp3-expressing regulatory T cells Nat Immunol 6 2005 1142 1151
74. T. Barthlott, H. Moncrieffe, M. Veldhoen, C.J. Atkins, J. Christensen, and A. O'Garra CD25(+)CD4(+) T cells compete with naive CD4(+) T cells for IL-2 and exploit it for the induction of IL-10 production Int Immunol 17 2005 279 288
75. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer Inducing and expanding regulatory T cell populations by foreign antigen Nat Immunol 6 2005 1219 1227
76. P. Pandiyan, L.X. Zheng, S. Ishihara, J. Reed, and M.J. Lenardo CD4(+) CD25(+) Foxp3(+) regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4(+) T cells Nat Immunol 8 2007 1353 1362
77. T. Manigold, E.C. Shin, E. Mizukoshi, K. Mihalik, K.K. Murthy, and C.M. Rice Foxp3(+)CD4(+)CD25(+) T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C Blood 107 2006 4424 4432
78. D. Franceschini, M. Paroli, V. Francavilla, M. Videtta, S. Morrone, and G. Labbadia PD-L1 negatively regulates CD4(+)CD25(+)Foxp3(+) Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV J Clin Invest 119 2009 551 564
79. M.H.J. Heeg, A. Ulsenheimer, N.H. Gruner, R. Zachoval, M.C. Jung, and J.T. Gerlach FOXP3 expression in hepatitis C virus-specific CD4(+) T cells during acute hepatitis C Gastroenterology 137 2009 1280 1288
80. Y. Belkaid Regulatory T cells and infection: a dangerous necessity Nat Rev Immunol 7 2007 875 888
81. S.M. Ward, B.C. Fox, P.J. Brown, J. Worthington, S.B. Fox, and R.W. Chapman Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection J Hepatol 47 2007 316 324
82. H. Ebinuma, N. Nakamoto, Y. Li, D.A. Price, E. Gostick, and B.L. Levine Identification and in vitro expansion of functional antigen-specific CD25(+) FoxP3(+) regulatory T cells in hepatitis C virus infection J Virol 82 2008 5043 5053
83. A.A.C. Mark, J.D.K. Robert, W.T. Hugo, L.A.J. Harry, and B. André Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis J Hepatol 52 2010 315 321
84. A. Tan, S.H. Yeh, C.J. Liu, C. Cheung, and P.J. Chen Viral hepatocarcinogenesis: from infection to cancer Liver Int 28 2008 175 188
85. D.A. Landau, D. Saadoun, L.H. Calabrese, and P. Cacoub The pathophysiology of HCV induced B-cell clonal disorders Autoimmun Rev 6 2007 581 587
86. M.A. West, R.P.A. Wallin, S.P. Matthews, H.G. Svensson, R. Zaru, and H.G. Ljunggren Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling Science 305 2004 1153 1157
87. F. Sallusto, and A. Lanzavecchia Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression Immunol Rev 177 2000 134 140
88. F. Sallusto, C.R. Mackay, and A. Lanzavecchia The role of chemokine receptors in primary, effector, and memory immune responses Annu Rev Immunol 18 2000 593
89. S. Romagnani The Th1/Th2 paradigm Immunol Today 18 1997 263 266
90. E.V. Acosta-Rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, and A. Lanzavecchia Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 2007 639 646
91. E. Bettelli, T. Korn, and V.K. Kuchroo Th17: the third member of the effector T cell trilogy Curr Opin Immunol 19 2007 652 657
92. C. Dong T-H 17 cells in development: an updated view of their molecular identity and genetic programming Nat Rev Immunol 8 2008 337 348
93. K. Nelms, A.D. Keegan, J. Zamorano, J.J. Ryan, and W.E. Paul The IL-4 receptor: signaling mechanisms and biologic functions Annu Rev Immunol 17 1999 701 738